IGF-I signaling was identified as a contributing factor in the Warburg effect, increased glucose uptake and a metabolic switch from butyrate oxidation to aerobic glycolysis, which is one of the hallmarks of CRC [72]. The gene discussed is IGF1; the disease is colorectal carcinoma.